NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, inc.

Financial giants and analyst raise concerns of a possible recession if the Trump administration moves forward with high tariffs. Here's what's happening.

Highmark Health today announced consolidated financial results for the full-year 2024, reporting $29.4 billion in revenue, ...

Specialist engineering services provider Ipsum has expanded its presence in the north-east region of England, UK, with the ...

Food-delivery company Wonder announced a deal to acquire independent media firm Tastemade, which produces original content ...

It goes without saying that market selloffs never feel particularly good for investors. The ongoing slide in tech stocks continues, with the ...

Parker’s Kitchen has named Darrin Samaha as its new vice president of marketing, the company announced on Monday. In his role ...

Israel and Lebanon held preliminary talks on potentially completing an Israeli troop withdrawal from the Arab country and ...

Interlink Electronics, Inc. (Nasdaq: LINK), a leading provider of sensor and printed electronics solutions, has engaged Gateway Group (Gateway), a leading strategic financial communications and ...

We recently published a list of 10 Stocks With At Least $30 Million In Insider Sales Recently. In this article, we are going ...

The Indian rupee is likely to stay under pressure on Tuesday, as concerns over a potential tariff-driven U.S. recession ...

Depending on the year and how it was circulated, some $2 bills are now worth thousands. Here's how to check the value of your bills.